Surat, July 03, 2023: Anupam Rasayan (NSE, BSE: ANURAS), one of India’s leading custom synthesis & speciality chemicals manufacturer, inks Memorandum of Understanding (MoU) with 3xper Innoventure Limited, a subsidiary of Tube Investments of India Limited a leading business conglomerates of India for supply of targeted and identified new age pharma molecules. The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models.
Speaking about the MoU, Anand Desai, Managing Director of Anupam Rasayan, said, “We are elated to embark on this technical collaboration which will leverage Anupam’s strong process optimisation capabilities and allowing us to build upon the existing robust pipeline of new age pharma molecules with focus on continuous processes. This is a natural extension of our company’s capabilities built over a decade in flow chemistry to manufacture niche pharma intermediates for various key customers on custom manufacturing model. The MoU perfectly aligns with our strategic objective of increasing the target market for our chemistries and expanding our pharma portfolio in an accelerated manner by enhancing the product basket offerings. It serves as yet another testament to our long-term revenue visibility and sustainable business model.”
Further to add, N.Govindarajan, CEO of 3xper Innoventure Limited said, “3xper is delighted to forge this collaboration to leverage each other’s capabilities and create value. We are a young and nimble organisation and forging this kind of collaboration will help 3xper to enhance its playing field and reach to global customers. This collaboration fits into our strategic imperatives to fulfil our aspirations to become the global CDMO with differentiated technology platforms to leverage and foster innovation for the customers.”
About Anupam Rasayan India Ltd. (ARIL):
Anupam Rasayan India Ltd (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Incorporated in 1984, the speciality chemicals major has two verticals: Life science related Specialty Chemicals comprising products related to Agrochemicals, Personal Care and Pharmaceuticals, Other Specialty Chemicals comprising Specialty Pigment and Dyes, and Polymer Additives.
The Company caters to a diverse base of Indian and global customers. It is currently manufacturing products for over 71 domestic and international customers, including 27 multinational companies. The Company operates via its six manufacturing facilities in Gujarat, India, with four facilities located at Sachin, Surat and two located at Jhaghadia, Bharuch with an aggregate installed capacity of about 27,000 MT as of 31st March 2023. ARIL offers multistep synthesis and undertakes complex chemical reactions technologies, for a diverse base of Indian and global customers.
About 3xper Innoventure Limited:
3xper Innoventure Limited is the subsidiary of Tube Investments of India Limited which is part of diverse conglomerate, The Murugappa Group. Founded in 1900, Murugappa Group is one of India's leading business conglomerates. The Group has 29 businesses including ten listed companies traded in NSE & BSE.
3xper Innoventure is a pioneering new Contract Development and Manufacturing Organization (CDMO) catering to global innovator companies seeking discovery, development and manufacturing solutions in starting materials, intermediates and active ingredients. As the go- to hub for innovation, 3xper is expected to deliver ease, efficiency, and economy to its clients. Founded by a leadership team with a stellar track record and backed by an eminent business group, 3xper will offer a seamless range of services under one roof for its global customers.
No comments:
Post a Comment